Empagliflozin Attenuates Non-Alcoholic Fatty Liver Disease (NAFLD) in High Fat Diet Fed ApoE(-/-) Mice by Activating Autophagy and Reducing ER Stress and Apoptosis
Narjes Nasiri‐Ansari(National and Kapodistrian University of Athens), Eva Kassi(National and Kapodistrian University of Athens)
Cited by 288
Related Papers
Canagliflozin attenuates the progression of atherosclerosis and inflammation process in APOE knockout mice
|Cardiovascular Diabetology|2018|161
Estrogen Receptor Subtypes Elicit a Distinct Gene Expression Profile of Endothelial-Derived Factors Implicated in Atherosclerotic Plaque Vulnerability
|International Journal of Molecular Sciences|2022|14